BMO Capital analyst Shannon Coyne is telling clients to buy Clorox (NYSE: CLX) on today's weakness.Coyne commented, "CLX reported 2Q/18 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE